# IriSys contract with NCI doubled to $6M for clinical trial materials

IriSys, LLC was awarded a $6 million increase in its five-year prime vendor contract with the National Cancer Institute for manufacturing clinical trial materials, doubling the ceiling.

- Type: Contract
- Announced: 2017-04-20
- Where: San Diego, United States
- Value: $6.00M
- Status: completed
- Products: clinical trial materials, pharmaceutical dosage forms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [IriSys](https://endata.com/companies/23716.md)
- [National Cancer Institute](https://endata.com/companies/23717.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/irisys-inc-contract-with-nci-for-manufacturing-clinical-trial-materials-is-doubled-in-value), 2017-04-20: "IriSys' consistent delivery of quality clinical trials materials to NCI on a timely basis is an example of our client-focused approach."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.